928008-25-7

Basic information

• Product Name: tert-butyl {(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridin-7-yl}carbamate
• Synonyms: tert-butyl {(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridin-7-yl}carbamate
• CAS NO: 928008-25-7
• Molecular Weight: 418.419
• Mol File: 928008-25-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tert-butyl {(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridin-7-yl}carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl {(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridin-7-yl}carbamate(928008-25-7)
• EPA Substance Registry System: tert-butyl {(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridin-7-yl}carbamate(928008-25-7)

Safety Data

• Hazardous Substances Data: 928008-25-7(Hazardous Substances Data)

Upstream product

• 888321-35-5 [(R)-6-oxo-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamic acid tert-butyl ester 
• 239137-39-4 3-amino-4-bromopyridine 

Relevant articles and documents

Asymmetrie synthesis of a potent, aminopiperidine-fused imidazopyridine dipeptidyl peptidase IV inhibitor

Chemical Equetion Presentation A practical asymmetric synthesis of a novel aminopiperidine-fused Imidazopyridine dipeptidyl peptidase IV (DPP-4) inhibitor 1 has been developed. Application of a unique three-component cascade coupling with chiral nitro diester 7, which is easily accessed via a highly enantioselective Michael addition of dimethyl malonate to a nitrostyrene, allows for the assembly of the functionalized piperidinone skeleton in one pot. Through a base-catalyzed, dynamic crystallization-driven process, the cis-piperidionone 16a is epimerized to the desired trans isomer 16b, which is directly crystallized from the crude reaction stream in high yield and purity. Isomerization of the allylamide 16b in the presence of RhCl3 is achieved without any epimerization of the acid/base labile stereogenic center adjacent to the nitro group on the piperidinone ring, while the undesired enamine intermediate is consumed to 3. The amino lactam 4, obtained through hydrogenation and hydrolysis, is isolated as its crystalline pTSA salt from the reaction solution directly, as such intramolecular transamidation has been dramatically suppressed via kinetic control. Finally, a Cu(I) catalyzed coupling-cyclization allows for the formation of the tricyclic structure of the potent DPP-4 inhibitor 1. The synthesis, which is suitable for large scale preparation, is accomplished in 23% overall yield.